Abstract
P2 Science has raised $12 million in a series C financing round. Chanel and lead investor HG Ventures join existing investors, including Xeraya Capital and BASF Venture Capital. The company says it will use a portion of the proceeds to expand capacity at its facility in Naugatuck, Connecticut. One of C&EN’s 10 Start-Ups to Watch in 2017, P2 Science conducts ozonolysis in a flow-chemistry reactor to make specialty chemicals.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
